Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy

American Journal of Medical Genetics

Volumn 75, Issue 3, 1998, Pages 314-317

  Egashira, Masayuki ^a   Ariga, Tadashi ^b   Kawamura, Nobuaki ^b   Miyoshi, Osamu ^a   Niikawa, Norio ^a   Sakiyama, Yukio ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ADA SCID gene therapy; Two color interphase FISH

Indexed keywords

ADENOSINE DEAMINASE;

ARTICLE; CASE REPORT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME DEFICIENCY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE THERAPY; HUMAN; HUMAN CELL; INTERPHASE; MALE; PATIENT MONITORING; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; TRANSGENE;

3T3 CELLS; ADENOSINE DEAMINASE; ANIMALS; CHILD, PRESCHOOL; GENE THERAPY; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MICE; SEVERE COMBINED IMMUNODEFICIENCY; TRANSGENES;

ADA;

EID: 0032559186     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980123)75:3<314::AID-AJMG18>3.0.CO;2-S     Document Type: Article

References (11)

1. Blaese RM (1993): Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency. Pediatr Res 33:49-55.
2. Blaese RM, Anderson WF, Culver KW (1990): The ADA human gene therapy clinical protocol. Hum Gene Ther 1:327-362.
3. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF (1995): T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270:475-480.
4. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F (1995): Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470-475.
5. Hirschhorn R, Yang DR, Israni A, Huie ML and Ownby DR (1994): Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet 55:59-68.
6. Jhanwar SC, Berkvens TM, Breukel C, van Ormondt H, van der Eb AJ, Khan MP (1989): Localization of human adenosine deaminase (ADA) gene sequences to the q12-q13.11 region of chromosome 20 by in situ hybridization. Cytogenet Cell Genet 50:168-171.
7. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annet G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R (1995): Engraftment of gene-modified umbilical cord bloody cells in neonates with adenosine deaminase deficiency. Nature Med 1:1017-1023.
8. Markert ML (1994): Molecular basis of adenosine deaminase deficiency. Immunodeficiency 5:141-157.
9. Nederlof PM, van der Flier S, Wiegant J, Raap AK, Tanke HJ, Ploem JS, van der Ploeg M (1990): Multiple fluorescence in situ hybridization. Cytometry 11:126-131.
10. OMIM (1997): "Online Mendelian Inheritance in Man." Release MIM10+. Johns Hopkins University (8,783 entries) through DBGET Data Base Links (http://www.genome.ad.jp).
11. Onodera M, Ariga T, Kawamura N, Kobayashi I, Otsu M, Yamada M, Tame A, Furuta H, Okano M, Matsumoto S, Kotani H, McGarrity GJ, Blaese RM, Sakiyama Y (1997): Successful peripheral T lymphocyte-directed gene therapy for an ADA-SCID patient. Blood (in press).